New Data Analyses Provide Insights That May Help Predict COPD Exacerbation Risk

RIDGEFIELD, Conn., Oct. 17, 2016 /PRNewswire/ — Boehringer Ingelheim today announced new data analyses from the Phase III TONADO® 1&2 trials that build upon existing evidence about the factors that increase the risk of a COPD exacerbation. These data were presented today at the… http://www.prnewswire.com/news-releases/new-data-analyses-provide-insights-that-may-help-predict-copd-exacerbation-risk-300345675.html